21st Century Oncology has begun a new research partnership with the University of Arizona's Center for Applied NanoBioscience and Medicine in Phoenix.
The partnership combines scientific and clinical expertise from both groups to study radiation-induced mechanisms and specific biosignatures in advanced radiotherapy, the company said.
The partners intend to propose at least two research programs during the calendar year and will share technology, materials, research sites, and additional resources.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
